Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.34 |
| ▸ | SERPINE1 | P05121 | 2/20 | 0.33 |
| ▸ | ACLY | P53396 | 3/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23348413 | 0.92 | KIF11 (0.35) | KIF11PTPN5SERPINE1ACLYPGR | |
| SCHEMBL23348332 | 0.91 | KIF11 (0.32) | KIF11 | |
| SCHEMBL23348472 | 0.91 | PGR (0.35) | KIF11PTPN5ACLYPGR | |
| SCHEMBL23348287 | 0.90 | KIF11 (0.40) | KIF11PTPN5SERPINE1PGRRXRA | |
| SCHEMBL23348463 | 0.89 | KIF11 (0.36) | KIF11PTPN5SERPINE1ACLYPGR | |
| SCHEMBL23348316 | 0.89 | KIF11 (0.39) | KIF11PTPN5SERPINE1ACLYPGR | |
| SCHEMBL22156840 | 0.89 | RORC (0.35) | KIF11PGR | |
| SCHEMBL22156823 | 0.89 | PGR (0.38) | KIF11PTPN5ACLYPGR | |
| SCHEMBL22156846 | 0.89 | KIF11 (0.35) | KIF11PGR | |
| SCHEMBL23348458 | 0.88 | PGR (0.38) | KIF11PTPN5SERPINE1ACLYPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210139425-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139425-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CCND2, CCND1, CRY1 | KIF11 1724/4885PTPN5 4876/4885SERPINE1 4594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.